Track TetraLogic Pharmaceuticals's receivables ($0) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
TetraLogic Pharmaceuticals (TLOG) currently reports a receivables of $0 as of September 2016. In the prior-year period, the figure was $0. Use the charts on this page to explore TetraLogic Pharmaceuticals's receivables history and peer comparisons.
TetraLogic Pharmaceuticals's receivables changed from $0 to $0 (period ending September 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
TetraLogic Pharmaceuticals reported $0 in receivables as of September 2016. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TetraLogic Pharmaceuticals, and consider following TLOG for alerts when major investors trade the stock.
TetraLogic Pharmaceuticals is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLOG with unrelated industries.